The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol deposits linked to age-related macular degeneration, potentially preventing ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Ocutrx Technologies Inc. ("Ocutrx"), through its R&D division Genius Labs, today unveiled a major surgical innovation: the ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Dry age-related macular degeneration (AMD) is the most common form of AMD and geographic atrophy (GA) is an advanced form of dry AMD, an eye disease that is a leading cause of blindness in the elderly ...

In patients with neovascular age-related macular degeneration (AMD), one of the most vision-threatening complications is submacular hemorrhage (SMH), a condition that can rapidly destroy central ...

Wet age-related macular degeneration (wet AMD) is a leading cause of severe, irreversible vision loss affecting approximately 14.5 million individuals globally and 1.7 million in the United States ...

BEDFORD, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today ...